10/06/2026
With decades of clinical and scientific leadership Prof. Michal Lotem, Director of the Hadassah Cancer Research Institute (HCRI), has been advancing innovative approaches to cancer treatment, bridging immunotherapy and RNA biology to address some of the most pressing unmet needs in oncology.
As the founder and coordinator of the European CANCERNA consortium—together with Prof. Rotem Karni—she has led a unique multidisciplinary effort to develop next-generation RNA-based cancer therapies. This initiative has brought together leading researchers, clinicians, and industry partners across Europe to translate cutting-edge science into real clinical impact.
Building on this momentum, Prof. Lotem also initiated the RNA Horizons Symposium, creating a global platform for collaboration between academia and industry in the rapidly evolving field of RNA therapeutics. Her work reflects not only scientific excellence, but also a strong commitment to international collaboration and innovation.
We are proud to see Prof. Michal Lotem, Director of the Hadassah Cancer Research Institute (HCRI), featured for her pioneering work at the forefront of cancer immunotherapy and RNA-based therapeutics.
With decades of clinical and scientific leadership, Prof. Lotem has been advancing innovative approaches to cancer treatment, bridging immunotherapy and RNA biology to address some of the most pressing unmet needs in oncology.
As the founder and coordinator of the European CANCERNA consortium—together with Prof. Rotem Karni—she has led a unique multidisciplinary effort to develop next-generation RNA-based cancer therapies. This initiative has brought together leading researchers, clinicians, and industry partners across Europe to translate cutting-edge science into real clinical impact.
Building on this momentum, Prof. Lotem also initiated the RNA Horizons Symposium, creating a global platform for collaboration between academia and industry in the rapidly evolving field of RNA therapeutics.
Her work reflects not only scientific excellence, but also a strong commitment to international collaboration and innovation—placing Israel at the forefront of global cancer research.
For more information about Hadassah International activities worldwide, check out our official website: https://hadassahinternational.org/